Ayurcann Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Ayurcann Holdings şirketinin toplam hissedar öz sermayesi CA$534.9K ve toplam borcu CA$164.8K olup, bu da borç-öz sermaye oranını 30.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CA$14.9M ve CA$14.3M dir.

Anahtar bilgiler

30.8%

Borç/özkaynak oranı

CA$164.81k

Borç

Faiz karşılama oranı	n/a
Nakit	CA$389.09k
Eşitlik	CA$534.88k
Toplam yükümlülükler	CA$14.32m
Toplam varlıklar	CA$14.85m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Even With A 88% Surge, Cautious Investors Are Not Rewarding Ayurcann Holdings Corp.'s (CSE:AYUR) Performance Completely

Jun 28

Not Many Are Piling Into Ayurcann Holdings Corp. (CSE:AYUR) Stock Yet As It Plummets 33%

May 11

Market Cool On Ayurcann Holdings Corp.'s (CSE:AYUR) Revenues Pushing Shares 29% Lower

Mar 22

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: AYUR 'nin kısa vadeli varlıkları ( CA$11.5M ) kısa vadeli yükümlülüklerini ( CA$13.6M ) kapsamıyor.

Uzun Vadeli Yükümlülükler: AYUR şirketinin kısa vadeli varlıkları ( CA$11.5M ) uzun vadeli yükümlülüklerini ( CA$714.6K ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: AYUR şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: AYUR şirketinin borç/öz sermaye oranı son 5 yılda 0% seviyesinden 30.8% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: AYUR şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: Serbest nakit akışı her yıl % 46.4 oranında tarihsel oranda büyümeye devam ederse AYUR un bir yıldan az nakit akışı süresi vardır.

Ayurcann Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) cancelled the acquisition of Ayurcann Holdings Corp. (CNSX:AYUR).

Full year 2024 earnings released: CA$0.022 loss per share (vs CA$0.035 loss in FY 2023)

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) entered into a definitive business combination agreement to acquire Ayurcann Holdings Corp. (CNSX:AYUR).

Even With A 88% Surge, Cautious Investors Are Not Rewarding Ayurcann Holdings Corp.'s (CSE:AYUR) Performance Completely

Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.007 loss in 3Q 2023)

Not Many Are Piling Into Ayurcann Holdings Corp. (CSE:AYUR) Stock Yet As It Plummets 33%

Market Cool On Ayurcann Holdings Corp.'s (CSE:AYUR) Revenues Pushing Shares 29% Lower

Second quarter 2024 earnings released: CA$0.005 loss per share (vs CA$0.001 loss in 2Q 2023)

First quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.007 loss in 1Q 2023)

Ayurcann Holdings Corp., Annual General Meeting, Dec 20, 2023

Full year 2023 earnings released: CA$0.035 loss per share (vs CA$0.026 loss in FY 2022)

Ayurcann Holdings Corp. Provides Corporate Update

Third quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.005 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.001 profit in 1Q 2022)

High number of new and inexperienced directors

Ayurcann Holdings Corp., Annual General Meeting, Dec 21, 2022

Full year 2022 earnings released: CA$0.026 loss per share (vs CA$0.003 loss in FY 2021)

Ayurcann Holdings Corp. Expands Product Offerings Across Canada

Ayurcann Holdings Corp. (CNSX:AYUR) completed the acquisition of Joints and Hustle & Shake Inc. from Tetra Oils Inc. for CAD 3.6 million.

Third quarter 2022 earnings released: CA$0.005 loss per share (vs CA$0.011 loss in 3Q 2021)

High number of new and inexperienced directors

Ayurcann Holdings Corp. Receives Flower Sales Licence from Health Canada

Ayurcann Holdings Corp. (CNSX:AYUR) signed a letter of intent to acquire 100% interest in Joints and Hustle & Shake Inc. from Tetra Oils Inc.

Consensus forecasts updated

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in FY 2020)

Ayurcann Holdings Corp. announced that it has received CAD 0.602832 million in funding

Ayurcann Holdings Corp. announced that it expects to receive CAD 0.5 million in funding

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin